What is the role of Megace (megestrol acetate) as an appetite stimulant for weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Megestrol Acetate as an Appetite Stimulant for Weight Gain

Megestrol acetate is effective for appetite stimulation and weight gain in patients with cancer-related anorexia/cachexia, but carries significant risks including thromboembolic events (1 in 6 patients) and increased mortality (1 in 23 patients). 1, 2

Efficacy and Indications

  • FDA-approved for treatment of anorexia, cachexia, or unexplained significant weight loss in patients with AIDS 3
  • Commonly used off-label for cancer-related anorexia/cachexia 1, 2
  • Effectiveness:
    • 1 in 4 patients experience increased appetite
    • 1 in 12 patients achieve weight gain 1
    • Weight gain primarily consists of fat mass rather than lean body mass 4

Dosing Recommendations

  • Minimum effective dose: 160 mg/day 2, 5
  • Optimal dose range: 480-800 mg/day 2
  • No evidence that doses above 480 mg/day provide additional efficacy 2
  • Dose-response relationship exists for appetite stimulation, but higher doses increase cost and side effects 5

Risk Profile

Megestrol acetate carries significant risks that must be carefully considered:

  • Thromboembolic events: 1 in 6 patients (relative risk 1.84) 1, 2
  • Mortality risk: 1 in 23 patients will die (relative risk 1.42) 1, 2
  • Edema (relative risk 1.36) 2
  • No significant improvement in quality of life compared to placebo 6, 7

Comparative Effectiveness

  • Superior to dronabinol (cannabis derivatives) for weight gain (75% vs 49% of patients) and appetite improvement (11% vs 3%) in cancer patients 1
  • More effective than placebo for weight gain (mean difference 2.25 kg) 6
  • Combination therapy approaches may yield better outcomes:
    • Megestrol acetate + L-carnitine + celecoxib + antioxidants improves lean body mass, appetite, and quality of life compared to megestrol acetate alone 1, 2

Clinical Algorithm for Use

  1. First, address reversible causes of anorexia (depression, pain, constipation, nausea/vomiting, oral candidiasis) 1, 2
  2. Consider megestrol acetate when:
    • Patient has cancer or AIDS-related anorexia/cachexia
    • Life expectancy is months-to-weeks or weeks-to-days
    • Increased appetite is an important aspect of quality of life 1
  3. Start at 160 mg/day, can increase to 480 mg/day if needed 2, 5
  4. Monitor weekly for:
    • Weight changes
    • Thromboembolic complications
    • Fluid retention 2
  5. Discontinue if ineffective after 4 weeks 2

Important Caveats

  • Weight gain is primarily fat mass, not lean body mass 4
  • Consider combining with exercise program when appropriate to maintain lean body mass 4
  • Particularly effective in women with cancer-related cachexia 4
  • May be beneficial in pediatric cancer patients with fewer side effects than in adults 8
  • Should be used in conjunction with non-pharmacological approaches (small frequent meals, high-calorie foods, pleasant eating environment) 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Appetite Stimulation in Patients with Cancer and Other Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Megestrol acetate: promises and pitfalls.

AIDS patient care and STDs, 1999

Research

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993

Research

Megestrol acetate for cachexia-anorexia syndrome. A systematic review.

Journal of cachexia, sarcopenia and muscle, 2018

Research

Megestrol acetate for treatment of anorexia-cachexia syndrome.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.